CSFZX | JACRX | CSFZX / JACRX | |
Total Expense Ratio | 0.84 | 2.21 | 38% |
Annual Report Gross Expense Ratio | 0.84 | 2.21 | 38% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 6.758 | 9.217 | 73% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.99B | 265M | 752% |
Annual Yield % from dividends | 2.67 | 2.05 | 130% |
Returns for 1 year | 9.97 | 13.70 | 73% |
Returns for 3 years | 15.38 | 3.69 | 416% |
Returns for 5 years | 30.75 | 0.51 | 5,976% |
Returns for 10 years | 46.53 | -14.57 | -319% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NQGIX | 38.58 | -0.40 | -1.03% |
Nuveen Global Equity Income I | |||
PCAQX | 81.30 | -1.02 | -1.24% |
Principal Capital Appreciation R5 | |||
GSPIX | 40.48 | -0.54 | -1.32% |
Goldman Sachs Large Cap Equity Instl | |||
UGOFX | 11.76 | -0.16 | -1.34% |
Victory Global Managed Volatility Instl | |||
PHPIX | 22.72 | -0.46 | -1.98% |
ProFunds Pharmaceuticals UltraSector Inv |